26 June 2018 | David A Benrimoh, Sonia Israel, Robert Fratila, Kelly Perlman
Globally, depression affects over 300 million people at any given time and is the leading cause of disability. While different patients may benefit more from different therapies, there is no principled way for clinicians to predict individual patient responses or side effect profiles.
19 June 2018 | Family Medicine Research Day
This special conference proceedings issue of the McGill Journal of Medicine features the top 16 abstracts from the 4th Annual Family Medicine Research day jointly hosted by the Family Medicine Graduate Student Society and the Research Division of the Department of Family Medicine held on May 30, 2018 at Thomson House.
16 May 2018 | Russel Yanofsky, Eric Sonke
On this episode we're very grateful to have interviewed PhD candidate Devin Abrahami, the first author of the paper "Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study" published in the March 2018 issue of the British Medical Journal.
18 April 2018 | Stephanie Thibaudeau, Julian Diaz-Abele, Mario Luc
No study in the literature has compared different external distractors for proximal interphalangeal joint (PIPJ) injury. We compared an elastic based device described by Suzuki et al. to a 2-pin model described by Hynes and Giddins in non-injured cadaveric fingers.
16 March 2018 | EBOH: Epidemiology, Biostatistics and Occupational Health
Selected abstracts from the 14th Annual Epidemiology, Biostatistics and Occupational Health Student Research Day, hosted by the Epidemiology, Biostatistics and Occupational Health Student Society on March 16, 2018 at the Montreal Neurological Institute.
11 March 2018 | Russel Yanofsky, Eric Sonke
Paul Savage is an MD-PhD student in the lab of Dr. Morag Park at the Goodman Cancer Research Centre in Montreal, Canada. In this episode, we discuss his latest article published in the October 2017 edition of Cell Reports.
16 January 2018 | David Haile-Meskale, Ron Olivenstein, Toby Mcgovern, Cathy Fugere, James G. Martin
Severe atopic asthma is poorly controlled with standard treatments, including optimally dosed corticosteroids. A humanized monoclonal antibody binding immunoglobulin E, omalizumab, is approved by the US Food and Drug Administration to treat poorly controlled asthma with elevated serum IgE levels.
20 December 2017 | Julie Chakriya Kvann, Stephanie Thibaudeau, Alain Joe Azzi, Teeanoosh Zadeh
In the reconstruction of the mangled lower extremity, muscle flaps are well known for their reliable use in soft tissue coverage, however, very few reports document their functional reconstruction potential as neurotized muscle flaps. This case illustrates that free neurotized latissimus dorsi flaps are a good option for long-term functional reconstruction in the mangled lower extremity.
03 November 2017 | Svetlana Puzhko
A report by Québec Health and Welfare commissioner Robert Salois, released on June 2, 2016, stated the obvious: our province has “the worst emergency [department] (ED) wait times in the Western world”.